Onderneming MYnd Analytics Inc Nasdaq
Aandelen
US62857N2027
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 21 | 100,0 % | 18 | 100,0 % | -10,77% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 21 | 100,0 % | 18 | 100,0 % | -10,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Sekulich
PSD | President | 59 | 01-05-19 |
Willis Lee
CHM | Chairman | 64 | 17-07-19 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 01-05-11 |
Mark Diamond
CIO | Chief Investment Officer | - | - |
Charles Stark
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-01-13 |
Lan T. Tran
ADM | Chief Administrative Officer | 48 | 17-07-19 |
Dale E. Short
SEC | Corporate Secretary | - | 01-09-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 17-07-19 |
Willis Lee
CHM | Chairman | 64 | 17-07-19 |
Ian Zwicker
BRD | Director/Board Member | 77 | 17-07-19 |
George Sekulich
PSD | President | 59 | 01-05-19 |
Seah LIm
BRD | Director/Board Member | 66 | 04-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 53 637 554 | 25 870 168 ( 48,23 %) | 0 | 48,23 % |
Bedrijfsgegevens
Emmaus Life Sciences, Inc.
21250 Hawthorne Boulevard Suite 800
90503, Torrance
+
http://www.emmausmedical.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+46,02% | 56,65 mld. | |
-6,52% | 39,44 mld. | |
+39,19% | 39,03 mld. | |
-6,65% | 26,86 mld. | |
+11,85% | 26,75 mld. | |
-21,60% | 19,03 mld. | |
+0,45% | 12,28 mld. | |
+23,53% | 12,26 mld. | |
+27,48% | 12,04 mld. |